INVESTER I NEW RAY MEDICINE INTERNATIONAL HOLDINGS MED ENDAVU: Køb New Ray Medicine International Holdings ($6108) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i New Ray Medicine International Holdings, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

New Ray Medicine International Holding Ltd. is a prominent player in the pharmaceutical industry, primarily focused on the distribution and marketing of pharmaceutical products throughout China. The company specializes in a diverse range of categories including prescription drugs, over-the-counter medicines, and health supplements, thereby addressing a broad spectrum of healthcare needs within the Chinese market. Their operations are well-integrated, covering various aspects of the supply chain from procurement to distribution, ensuring efficient delivery of quality pharmaceutical products. New Ray Medicine plays an important role in improving healthcare accessibility and contributes to the pharmaceutical sector's expansion in a rapidly growing economy. The company’s activities are significant within the healthcare infrastructure, supporting public health initiatives and catering to the needs of hospitals, clinics, and pharmacies. Through strategic partnerships and innovation in product offerings, New Ray Medicine International Holding Ltd. continues to strengthen its market position amidst China's evolving healthcare landscape.